Stocks to buy

Palantir Technologies (NYSE:PLTR) reported third-quarter results on Nov. 9, meeting earnings expectations and delivering a revenue beat. The company continues to add new customers at a healthy pace with strong growth projected in the coming years. Though government revenue dipped during the quarter, the compelling strides in Palantir’s commercial segment have more than made up
0 Comments
Here’s an interesting addition to your biotechnology-sector holdings: California-headquartered Progenity (NASDAQ:PROG) develops targeted therapeutics for diseases, and traders should be glad to know that PROG stock is usually affordable. The stock’s low price makes it prone to bouts of volatility however, which are not helped by recent short-squeeze runs. But the big swings don’t mean there’s
0 Comments
There’s a pretty good chance that you haven’t spent much of your time thinking about functional materials. As an enterprising investor, however, you could discover serious profit potential with Meta Materials (NASDAQ:MMAT), as MMAT stock offers pure-play exposure to this high-conviction market. Source: Yuriy Golub / Shutterstock.com To put it simply, meta materials are a
0 Comments
Novavax (NASDAQ:NVAX) bulls are finally rejoicing. Shares shot up after Indonesia, one of the top five most populous countries globally, greenlighted its vaccine recently. That came on the heels of the biotech filing emergency use authorization (EUA) packages with several authorities, including the world health organization (WHO) and the European Union (E.U.). All of this
0 Comments
Founded by somewhat eccentric billionaire Richard Branson, Virgin Galactic (NYSE:SPCE) is on a mission to make astronauts out of regular folks — who happen to have an extra several hundred thousand dollars lying around. You can invest in this intriguing mission with a position in SPCE stock. Source: Christopher Penler / Shutterstock.com To its credit, Branson’s
0 Comments
Plant-based stocks have attracted significant investor interest in the past year. Data released by The Good Food Institute reveals that $3.1 billion in investment capital went into alternative proteins globally in 2020. That amount was three times the capital raised in 2019. In addition, Meticulous Research suggests the plant-based market will grow at a compounded
0 Comments
Paypal (NASDAQ:PYPL) is a screaming buy after its recent earnings fiasco. PYPL stock fell 12% on Nov. 9 immediately after it announced third-quarter results and forward guidance that left Wall Street cringing. Source: JHVEPhoto / Shutterstock.com Paypal stock had its worst one-day performance in nearly two years due to the substandard results. The online payments
0 Comments